BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
ICICI Direct Report
Caplin Point Laboratories Ltd.’s Q3 FY21 operational performance was mostly in line with our expectations whereas profitability was below due to lower than expected other income.
Revenues grew 20.2% YoY to Rs 274 crore. Ebitda margins improved 89 basis points YoY to 30.6% due to higher gross margins, lower other expenses partly offset by higher staff costs likely due to acquired subsidiaries.
Hence, Ebitda grew 23.9% YoY to Rs 84 crore. However, profit after tax grew 10.1% YoY to Rs 64 crore due to lower other income and higher tax outgo.
Click on the attachment to read the full report:
DISCLAIMER
This report is authored by an external party. BloombergQuint does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of BloombergQuint.
Users have no license to copy, modify, or distribute the content without permission of the Original Owner.
As a Subscriber you get
Stories
RECOMMENDED FOR YOU
POPULAR